Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division.
Effective segregation of the bovine papillomavirus type 1 (BPV1), Epstein-Barr virus (EBV), and Kaposi's sarcoma-associated human herpesvirus type 8 (KSHV) genomes into daughter cells is mediated by a single viral protein that tethers viral genomes to host mitotic chromosomes. The linker proteins that mediate BPV1, EBV, and KSHV segregation are E2, LANA1, and EBNA1, respectively. The N-terminal transactivation domain of BPV1 E2 is responsible for chromatin attachment and subsequent viral genome segregation. Because E2 transcriptional activation and chromatin attachment functions are not mutually exclusive, we aimed to determine the requirement of these activities during segregation by analyzing chimeric E2 proteins. This approach allowed us to separate the two activities. Our data showed that attachment of the segregation protein to chromatin is not sufficient for proper segregation. Rather, formation of a segregation-competent complex which carries multiple copies of the segregation protein is required. Complementation studies of E2 functional domains indicated that chromatin attachment and transactivation functions must act in concert to ensure proper plasmid segregation. These data indicate that there are specific interactions between linker molecules and transcription factors/complexes that greatly increase segregation-competent complex formation. We also showed, using hybrid E2 molecules, that restored segregation function does not involve interactions with Brd4.
Silla
Toomas
T
Department of Biomedical Technology, Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.
Männik
Andres
A
Ustav
Mart
M
D000818:Animals; D052688:Bovine papillomavirus 1 / Q000235:genetics*; D002417:Cattle; D018797:Cell Cycle Proteins; D002455:Cell Division; D002843:Chromatin / Q000378:metabolism; D020090:Chromosome Segregation; D004268:DNA-Binding Proteins / Q000235:genetics; D016679:Genome, Viral; D019288:Herpesvirus 8, Human / Q000235:genetics; D054884:Host-Pathogen Interactions; D006801:Humans; D008938:Mitosis; D009687:Nuclear Proteins; D014157:Transcription Factors; D014764:Viral Proteins / Q000235:genetics; D000092468:Bromodomain Containing Proteins
D018797:Cell Cycle Proteins; D002843:Chromatin; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D014157:Transcription Factors; D014764:Viral Proteins; C441289:BRD4 protein, human; D000092468:Bromodomain Containing Proteins; C051550:E2 protein, Bovine papillomavirus
EMBO J. 2003 Feb 17;22(4):954-63
12574131
Proc Biol Sci. 2009 May 7;276(1662):1535-44
19203914
J Virol. 1991 Apr;65(4):2124-30
1848322
J Virol. 2009 Mar;83(6):2592-600
19129460
J Virol. 2004 Jan;78(1):294-301
14671111
Genes Cells. 2002 Jan;7(1):49-58
11856373
Adv Virus Res. 2008;72:155-205
19081491
J Virol. 2005 Aug;79(16):10528-39
16051845
Science. 1999 Apr 23;284(5414):641-4
10213686
EMBO J. 1992 Nov;11(11):4111-8
1327758
Cell. 1994 Aug 12;78(3):513-23
8062391
J Virol. 2006 Oct;80(19):9530-43
16973557
J Mol Biol. 2005 Feb 11;346(1):175-89
15663936
Cancer Res. 2004 Feb 15;64(4):1359-68
14973079
Mol Cell Biol. 1999 Dec;19(12):8123-35
10567538
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3822-7
16505361
Cell. 1990 Feb 9;60(3):375-86
2302733
Cell. 1994 Aug 12;78(3):525-34
8062392
Cancer Res. 2002 Dec 1;62(23):6959-65
12460913
J Virol. 1999 Jun;73(6):4670-7
10233926
J Virol. 2006 Apr;80(7):3660-5
16537635
J Virol. 1998 Mar;72(3):2079-88
9499063
Nature. 1991 Oct 10;353(6344):569-71
1922364
EMBO J. 1987 Nov;6(11):3391-7
2828029
J Virol. 1999 May;73(5):4404-12
10196338
J Virol. 2008 Dec;82(24):12009-19
18922874
Proc Natl Acad Sci U S A. 1983 Dec;80(24):7650-3
6324183
J Virol. 2002 Nov;76(22):11596-604
12388720
J Virol. 2006 May;80(9):4276-85
16611886
Virology. 1990 Jun;176(2):563-74
2161150
Nature. 1991 Jun 13;351(6327):588-90
1646402
Science. 1991 Jan 4;251(4989):87-90
1846049
J Virol. 2006 Nov;80(21):10772-86
16928766
Nature. 1988 Oct 6;335(6190):563-4
3047590
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4030-5
15020762
EMBO J. 1991 Dec;10(13):4321-9
1661672
Virology. 2000 Apr 25;270(1):124-34
10772985
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5799-803
1321423
J Virol. 2005 Apr;79(8):4806-18
15795266
J Virol. 2009 May;83(9):4326-37
19225000
J Biol Chem. 2002 Sep 6;277(36):32875-82
12107188
J Virol. 1996 Jul;70(7):4193-9
8676438
J Virol. 1996 Sep;70(9):6169-79
8709243
EMBO J. 1989 Aug;8(8):2337-42
2676518
Mol Cell. 2000 Sep;6(3):551-61
11030335
Virology. 1999 Nov 25;264(2):254-64
10562490
EMBO Rep. 2000 Aug;1(2):140-4
11265753
J Virol. 2007 Apr;81(8):4348-56
17287261
Mol Cell Biol. 1990 Nov;10(11):5914-20
2233723
Mol Cell. 2006 Dec 28;24(6):877-89
17189190
EMBO J. 1992 Apr;11(4):1383-90
1314165
Virology. 2009 Feb 20;384(2):360-8
19141359
J Virol. 1999 Apr;73(4):2587-95
10074103
EMBO J. 1996 Jan 2;15(1):1-11
8598191
J Biol Chem. 2007 May 4;282(18):13141-5
17329240
EMBO J. 1988 Sep;7(9):2823-9
2846285
Mol Cell Biol. 1995 Nov;15(11):6465-73
7565798
EMBO J. 1991 Feb;10(2):449-57
1846806
Nature. 1990 Jun 28;345(6278):783-6
2193231
J Virol. 1999 May;73(5):4385-92
10196336
J Virol. 2004 Feb;78(4):2100-13
14747575
Cell. 1985 Aug;42(1):183-91
2990724
Virology. 2007 Feb 5;358(1):10-7
17023018
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4338-43
9539738
Int J Cancer. 1989 Apr 15;43(4):672-6
2467886
J Virol. 2005 Feb;79(3):1500-9
15650176
J Virol. 2005 Dec;79(24):15277-88
16306599
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1047-52
16415162
J Virol. 2006 May;80(10):4792-800
16641272
J Virol. 2001 Apr;75(8):3948-59
11264383
Hum Gene Ther. 2009 Nov;20(11):1291-307
19627235
Cell. 2004 Apr 30;117(3):349-60
15109495
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):898-902
8381536
J Virol. 2010 Jan;84(1):543-57
19846509
Science. 2006 Feb 10;311(5762):856-61
16469929